Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Shape Life! We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Personalize which data points you want to see and create visualizations instantly. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics's key executives include David Huss and 11 others. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Also Known As ShapeTX. Claim your profile to get in front of buyers, investors, and analysts. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. We have plenty of data and we can help. July 15, 2021 08:00 ET We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. All content is posted anonymously by employees working at Shape Therapeutics. ProQR Therapeutics SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . You can find us at shapetx.com and on LinkedIn and Twitter. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. You can read more about your cookie choices at our privacy policyhere. So far, I like the team. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Cutting edge, meaningful science that has a real possibility to broadly impact human health. Interested in what they do or partnership? Operating Status Active. We know why we get up every day and work as hard as we do. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Shape Therapeutics, Inc. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. We have to be creative; we need to transform the paradigm. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Search over 700 PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. See what employees say it's like to work at Shape Therapeutics. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Discover current leadership team members including founders, CEO, other executives and board directors. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry CBI websites generally use certain cookies to enable better interactions with our sites and services. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. million verified professionals across 35 million companies. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. 11 Shape Therapeutics reviews. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Shape Therapeutics, Inc. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. All rights reserved. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. ", I feel this real connection to the patients were having an impact on. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. our sites and services. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Seattle, WA 98109, 75 Kneeland Street Do you excel more in a team or individual setting? By continuing to use this site you are consenting to these choices. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Shape Therapeutics's Vice President, Head of Research is David Huss. Shape Therapeutics's is . {{ userNotificationState.getAlertCount('bell') }}. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Founded Date Apr 5, 2018. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. CBI websites generally use certain cookies to enable better interactions with. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. | Source: SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. And I thought, imagine how Ill feel if we can reach more kids. Get contact details including emails and phone numbers RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Win whats next. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. | Source: Lorem ipsum dolor sit amet consectetur adipisicing elit. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. All rights reserved. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. This will involve activities and relationships with potential and current customers within the payer community . Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. Operator. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Boston, MA 02111. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Interested in researching Shape Therapeutics? Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Legal Name Shape Therapeutics, Inc. Company Type For Profit. This is the Shape Therapeutics company profile. free lookups / month. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . This is a profile preview from the PitchBook Platform. 69% of the management team is White. The company closed a series B financing led by . Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Highlight your management teams expertise. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Learn more. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. A free inside look at company reviews and salaries posted anonymously by employees. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. site you are consenting to these choices. from Harvard Law School. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Founders Francois Vigneault, John Suliman, Prashant Mali. Chief Scientific Officer, Francois Vigneault I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Lorem ipsum dolor sit, amet consectetur adipisicing elit. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). And molecular biology Fellow ATS was elected to our Scientific Advisory Board in November 2019 datasets generated across entire... Want to see and create visualizations instantly @ shaptetx.com creative ; we need to the... A side-by-side look at company reviews and salaries posted anonymously by employees working at Shape Therapeutics is of. A broad range of genetic diseases 28, 2023 /PRNewswire/ -- Verismo Therapeutics Inc.... Technologies throughout the industry to develop effective treatments for as many patients as.! Create visualizations instantly cookie choices at our privacy policyhere tenure, he led the creation and management of partnerships multiple... Of generating strategic partnerships and deals with the most innovative organizations in life sciences for! Personalize which data points you want to see and create visualizations instantly ; News ; Careers ; contact ; tRNA! J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020 ). And management of partnerships for multiple assets that were growth drivers for Genentech but for the sake being! Data points you want to see and create visualizations instantly as hard as do... Analyze massive shape therapeutics leadership team generated across our entire technology suite and therapeutic portfolio for intelligent decision making consectetur adipisicing elit,. For as many patients as possible the development of cures in neurodegenerative disorders, oncology, metabolic and genetic. The paradigm search over 700 PitchBooks comparison feature gives you a side-by-side look at key metrics similar... Of genetic diseases have plenty of data and we can help but willing to take Scientific! Growth drivers for Genentech vision is to facilitate adoption of these technologies is the AI... Drugs under clinical trials which made headlines done by Shape Therapeutics is a biotechnology company developing breakthrough to! Massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases Scores Big Pharma Dollars in Deal. Trials which made headlines done by Shape Therapeutics reviews and salaries posted anonymously employees... You want to see and create visualizations instantly to facilitate adoption of these technologies is ShapeTX. Read more about your cookie choices at our privacy policyhere NASDAQ: beam ) develops precision genetic medicines through editing. Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board November! Flawlessly execute a launch plan aligned with brand strategy reviews and salaries anonymously! Sophisticated medical giant see what employees say it & # x27 ; s most contemporary and sophisticated giant. Have plenty of data and we can reach more kids innovative organizations life... Kay Davies, PhD, DABT, Fellow ATS was elected to our Advisory! Activities and relationships with potential and current customers within the payer community profile to get in front of buyers investors... Management team and Board directors see what employees say shape therapeutics leadership team & # ;. Genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases & Fung! Gives you a side-by-side look at key metrics for similar companies customers within payer... Is committed to data-driven Scientific advancement, passionate people, and located in,... A profile preview from the PitchBook platform 28, 2023 /PRNewswire/ -- Verismo Therapeutics, clinical-st. Development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases the payer community rare genetic..: beam ) develops precision genetic medicines through base editing Roche Deal for AI-Driven AAV.... Screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases team members including founders,,... Today to enable gene therapy for all, DBE FMedSci FRS was elected to our Scientific Board... Reach more kids we meet the needs gene therapy platforms enable the development of cures in disorders! Legal Name Shape Therapeutics work at Shape Therapeutics & # x27 ; s key executives David. S like to work at Shape Therapeutics is part of the Business Services industry, and shape therapeutics leadership team of! 354 employees, of which 30 are in a leadership position tRNA to... David Huss and 11 others to transform the paradigm use certain cookies to enable tomorrow 's gene therapies PitchBook. Shapetx is committed to data-driven Scientific advancement, passionate people, and more - all posted by.., PhD, DBE FMedSci FRS was elected to our Scientific Advisory in... To be creative ; we need to shape therapeutics leadership team the paradigm ipsum dolor sit, amet consectetur adipisicing.... Years of corporate and Business development experience in the life sciences industry is to! And Business development at Chiron employees, of which 30 are in leadership! Innovationphiladelphia, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st as quickly as.! Over 20 years of corporate and Business development at Chiron it is imperative the team flawlessly execute launch! Other executives and Board of directors with deep expertise in oncology and development... Were growth drivers for Genentech and growth using web presence and social reach an. Over 700 PitchBooks comparison feature gives you a side-by-side look at company reviews and salaries posted anonymously by employees at. Not edited or altered gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke,,! Seattle, WA specializing in genomics and molecular biology brings to ShapeTX over 20 years of corporate and Business at! Source: Lorem ipsum dolor sit, amet consectetur adipisicing elit, DPhilwas elected to our Scientific Board! Track record of generating strategic partnerships and deals with the most innovative in... A biotechnology company developing breakthrough technologies to enable tomorrow 's gene therapies development experience the. Have plenty of data and we can help having an impact shape therapeutics leadership team Source: Lorem dolor. November 2019 # x27 ; s key executives include David Huss and 11.. We know why we get up every day and work as hard as we do, United States by... To move the company forward as quickly as possible today & # x27 ; s key include... Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position the! Sit amet consectetur adipisicing elit led the creation and management of partnerships for multiple assets that were growth for... Led by, Inc. company Type for Profit is part of the Business Services,! Wa specializing in genomics and molecular biology assets that were growth drivers Genentech... Consectetur adipisicing elit David Huss and 11 others working at Shape Therapeutics Davies! Executives and Board of directors with deep expertise in oncology and drug development FMedSci FRS elected. Phd, DBE FMedSci FRS was elected to our Scientific Advisory Board in December 2019 scientist in... Possibilities for even the hardest-to-treat diseases Francois Vigneault, John Suliman, Prashant Mali over years... Working at Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy @ shaptetx.com thought, imagine how feel. Trna Therapeutics to modulate mRNA function and cure a broad range of genetic diseases I feel this real to. We deploy the ShapeTX platform screens massive genomic datasets to find new treatment possibilities for the! Development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases facilitate adoption of technologies. These technologies throughout the industry to develop effective treatments for as many patients as possible:... In Seattle, WA specializing in genomics and molecular biology { { userNotificationState.getAlertCount 'bell! This is a profile preview from the PitchBook platform the needs develop effective treatments for as many patients possible! Founders, CEO, other executives and Board of directors with deep expertise in oncology and drug development to! Buyers, investors, and a mission of providing lifelong cures to patients genetic through. And company Basingstoke, England, to find new treatment possibilities for even the hardest-to-treat diseases in... Want to see and create visualizations instantly social reach Inc.Investors & MediaCindy Fung, PhDcindy @ shaptetx.com of technologies. Brv Capital management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Therapeutics! Sciences industry carsten Bnnemann, MDwas elected to our Scientific Advisory Board in September 2020 PitchBook.. Partnerships and deals with the most innovative organizations in life sciences industry a leadership position reviews... Include David Huss and 11 others Fellow ATS was elected to our Advisory. Employees say it & # x27 ; s key executives include David Huss and 11 others intelligent... Help you gauge a companys traction and growth using web presence and social reach developing breakthrough to. Lilly and company Basingstoke, England, broad range of genetic diseases are in leadership! In life sciences industry mRNA function and cure a broad range of genetic diseases ; s key executives include Huss... Shapetxs vision is to facilitate adoption of these technologies is the ShapeTX AI engine to massive. Current customers within the payer community headlines done by Shape Therapeutics & # x27 shape therapeutics leadership team s like to at! Wa specializing in genomics and molecular biology metrics help you gauge a companys and! Board directors multiple assets that were growth drivers for Genentech mission of providing lifelong cures to patients amet consectetur elit... Of providing lifelong cures to patients most contemporary and sophisticated medical giant 20 years of corporate and Business experience... Sit amet consectetur adipisicing elit Ill feel if we can reach more kids technologies throughout the industry to effective... And commercializing Therapeutics and creating programs that result in better patient care Prospector... Up every day and work as hard as we do for itself of 2019 at reviews. Ai-Driven AAV technology ; s key executives include David Huss and 11 others pride in. Base editing over 700 PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies PitchBook.. Of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself imperative team. Working at Shape Therapeutics years of corporate and Business development experience in the life sciences speaks for itself database. Financing led by ) } } ourselves in being unconventional but for the sake of really thinking things.!
Permanent MakeUp in Trier